Preparation and use of reverse protein microarrays

Current Protocols in Protein Science

Volumn 2014, Issue , 2014, Pages 27.7.1-27.29

  Pin, Elisa ^a,b   Federici, Giulia ^a,c   Petricoin, Emanuel F ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Analysis; Antibody; Cells; Microarray; Protein; Tissues

Indexed keywords

PROTEIN HYDROLYSATE;

ADHERENT CELL; ARTICLE; CELL CULTURE; CELL LYSATE; CELL SUSPENSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DETERMINATION; PROTEIN MICROARRAY; REVERSE PHASE PROTEIN MICROARRAY; TISSUE SECTION;

EID: 84928019428     PISSN: 19343655     EISSN: 19343663     Source Type: Journal    
DOI: 10.1002/0471140864.ps2707s75     Document Type: Article

References (17)

1. Bobrow, M.N., Harris, T.D., Shaughnessy, K.J., and Litt, G.J. 1989. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125:279-285.
2. Ekins, R.P. 1989. Multi-analyte immunoassay. J. Pharm. Biomed. Anal. 7:155-168.
3. Espina, V., Wulfkuhle, J., and Liotta, L.A. 2009. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. Clin. Lab. Med. 29:1-13.
4. Gyorgy, A.B., Walker, J., Wingo, D., Eidelman, O., Pollard, H.B., Molnar, A., and Agoston, D.V. 2010. Reverse phase protein microarray technology in traumatic brain injury. J. Neurosci. Methods 192:96-101.
5. Liotta, L.A., Espina, V., Mehta, A.I., Calvert, V., Rosenblatt, K., Geho, D., Munson, P.J., Young, L., Wulfkuhle, J., and Petricoin, E.F. III. 2003. Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell 3:317-325.
6. Luchini, A., Geho, D.H., Bishop, B., Tran, D., Xia, C., Dufour, R.L., Jones, C.D., Espina, V., Patanarut, A., Zhou, W., Ross, M.M., Tessitore, A., Petricoin, E.F. 3rd, and Liotta, L.A. 2008. Smart hydrogel particles: Biomarker harvesting: Onestep affinity purification, size exclusion, and protection against degradation. Nano Lett. 8:350-361.
7. Mazzone, M., Selfors, L.M., Albeck, J., Overholtzer, M., Sale, S., Carroll, D.L., Pandya, D., Lu, Y., Mills, G.B., Aster, J.C., Artavanis-Tsakonas, S., and Brugge, J.S. 2010. Dosedependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 107:5012-5017.
8. Miller, L.D., Long, P.M., Wong, L., Mukherjee, S., McShane, L.M., and Liu, E.T. 2002. Optimal gene expression analysis by microarrays. Cancer Cell 2:353-361.
9. Mueller, C., Liotta, L.A., and Espina, V. 2010a. Reverse phase protein microarrays advance to use in clinical trials. Mol. Oncol. 4:461-481.
10. Mueller, C., Zhou, W., Vanmeter, A., Heiby, M., Magaki, S., Ross, M.M., Espina, V., Schrag, M., Dickson, C., Liotta, L.A., and Kirsch, W.M. 2010b. The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J. Alzheimers Dis. 19:1081-1091.
11. Paweletz, C.P., Charboneau, L., Bichsel, V.E., Simone, N.L., Chen, T., Gillespie, J.W., Emmert-Buck, M.R., Roth, M.J., Petricoin, E.F. III, and Liotta, L.A. 2001. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981-1989.
12. Petricoin, E.F. III, Espina, V., Araujo, R.P., Midura, B., Yeung, C., Wan, X., Eichler, G.S., Johann, D.J. Jr., Qualman, S., Tsokos, M., Krishnan, K., Helman, L.J., and Liotta, L.A. 2007. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res. 67:3431-3440.
13. Rose, D. 2000. Microfluidic technologies and instrumentation for printing DNA microarrays. In Microarray Biochip Technology (M. Schena, ed.) pp. 19-38. Eaton Publishing, Natick, Mass.
14. Silvestri, A., Colombatti, A., Calvert, V.S., Deng, J., Mammano, E., Belluco, C., De Marchi, F., Nitti, D., Liotta, L.A., Petricoin, E.F., and Pierobon, M. 2010. Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab. Invest. 90:787-796.
15. Spurrier, B., Ramalingam, S., and Nishizuka, S. 2008. Reverse-phase protein lysate microarrays for cell signaling analysis. Nat. Prot. 3:1796-1808.
16. Tonkinson, J.L. and Stillman, B.A. 2002. Nitrocellulose: A tried and true polymer finds utility as a post-genomic substrate. Front. Biosci. 7:1-12.
17. VanMeter, A.J., Camerini, S., Polci, M.L., Tessitore, A., Trivedi, N., Heiby, M., Kamal, Y., Hansen, J., and Zhou, W. 2012. Serum low-molecular-weight protein fractionation for biomarker discovery. Methods Mol. Biol. 823:237-249.